Indeed, blockade of tumor-derived exosomal PD-L1 restores global anti-tumor immunity even in models resistant to anti-PD-L1, and this blockade suppresses tumor growth in addition to that produced by anti-PD-L1 antibodies (Poggio et al., 2019). This evidence concerns the gene CD274 and neoplasm.